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ABSTRACT
Background
The importance of understanding age when estimating the impact of influenza on
hospitalizations and deaths has been well described, yet existing surveillance systems have not
made adequate use of age-specific data. Monitoring influenza-related morbidity using
electronic health data may provide timely and detailed insight into the age-specific course,
impact and epidemiology of seasonal drift and reassortment epidemic viruses. The purpose of
this study was to evaluate the use of emergency department (ED) chief complaint data for
measuring influenza-attributable morbidity by age and by predominant circulating virus.
Methods and Findings
We analyzed electronically reported ED fever and respiratory chief complaint and viral
surveillance data in New York City (NYC) during the 2001–2002 through 2005–2006 influenza
seasons, and inferred dominant circulating viruses from national surveillance reports. We
estimated influenza-attributable impact as observed visits in excess of a model-predicted
baseline during influenza periods, and epidemic timing by threshold and cross correlation. We
found excess fever and respiratory ED visits occurred predominantly among school-aged
children (8.5 excess ED visits per 1,000 children aged 5–17 y) with little or no impact on adults
during the early-2002 B/Victoria-lineage epidemic; increased fever and respiratory ED visits
among children younger than 5 y during respiratory syncytial virus-predominant periods
preceding epidemic influenza; and excess ED visits across all ages during the 2003–2004 (9.2
excess visits per 1,000 population) and 2004–2005 (5.2 excess visits per 1,000 population) A/
H3N2 Fujian-lineage epidemics, with the relative impact shifted within and between seasons
from younger to older ages. During each influenza epidemic period in the study, ED visits were
increased among school-aged children, and each epidemic peaked among school-aged
children before other impacted age groups.
Conclusions
Influenza-related morbidity in NYC was highly age- and strain-specific. The impact of
reemerging B/Victoria-lineage influenza was focused primarily on school-aged children born
since the virus was last widespread in the US, while epidemic A/Fujian-lineage influenza
affected all age groups, consistent with a novel antigenic variant. The correspondence between
predominant circulating viruses and excess ED visits, hospitalizations, and deaths shows that
excess fever and respiratory ED visits provide a reliable surrogate measure of incident influenza-
attributable morbidity. The highly age-specific impact of influenza by subtype and strain
suggests that greater age detail be incorporated into ongoing surveillance. Influenza morbidity
surveillance using electronic data currently available in many jurisdictions can provide timely
and representative information about the age-specific epidemiology of circulating influenza
viruses.
The Editors’ Summary of this article follows the references.
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Throughout the twentieth century, epidemic and pandemic
inﬂuenza was responsible for causing widespread illness,
economic disruption, and considerable loss of life worldwide
[1–3]. While the seasonal recurrence of inﬂuenza is antici-
pated each year, it remains difﬁcult to predict the predom-
inant seasonal strains and impossible to know when and
where the next human pandemic will emerge. Timely regional
monitoring of inﬂuenza-related morbidity is a priority for
seasonal surveillance and pandemic preparedness [4].
Inﬂuenza surveillance currently conducted in the United
States encompasses systems for monitoring inﬂuenza-related
illness and death, investigating unusual respiratory disease
outbreaks, and identifying and characterizing viral inﬂuenza
strains [5]. The rapid epidemiological assessment of inﬂuen-
za-related morbidity and mortality remains a challenge for
public health due to the nonspeciﬁc symptoms, rarity of
laboratory conﬁrmation, and difﬁculty in obtaining contin-
uous, representative, and age-speciﬁc data [1,2]. Across the
US, inﬂuenza-like illness (ILI) and pneumonia and inﬂuenza
(P&I) mortality surveillance coordinated by the Centers for
Disease Control and Prevention (CDC) has relied on weekly
reporting of ILI visits by physicians in a voluntary sentinel
network, and of P&I deaths by participating municipal vital
records ofﬁces [5]. The primary shortcomings of these systems
include the burden on health department and physician
practices resulting in low and variable participation, with
reporting delays and an absence of timely year-round data
limiting their usefulness.
In recent years, New York City (NYC) and other juris-
dictions have tracked inﬂuenza using syndromic surveillance
systems such as those based on electronically reported
emergency department (ED) patient chief complaints [6].
Several studies based on these systems have reported seasonal
increases in respiratory or inﬂuenza-like syndrome visits
coincident with documented inﬂuenza epidemics [6–12].
Coded respiratory and inﬂuenza-like ED visits have been
reported to provide a timely, sensitive, and year-round
measure that enables detection of epidemic inﬂuenza 1–2
wk earlier than does P&I mortality data [7]; and age-speciﬁc
respiratory visits have been reported to show that data from
children aged 3–4 y provide the earliest indicator, leading
P&I mortality by 7 wk [8]. The absence of viral surveillance
data from these studies, however, leave important questions
unanswered: To what degree do early seasonal morbidity
increases correlate with actual inﬂuenza or other respiratory
virus circulation? And to what degree does circulating viral
type, subtype, and strain impact the timing and magnitude of
age-speciﬁc morbidity and mortality?
Epidemiologic community and family studies [13–18] and
retrospective analyses of mortality and hospitalization data
[19–27] have provided considerable insight into the age-
speciﬁc patterns of seasonal and epidemic inﬂuenza. Pro-
spective morbidity surveillance systems, however, have not
taken full advantage of age-speciﬁc data. Important epide-
miologic insights gained by scrutinizing how inﬂuenza
impacts speciﬁc age groups include evidence that inﬂuenza
often spreads earliest among school-age children [1,16–18];
that school breaks may slow or delay seasonal impact [1,16];
that age-speciﬁc impact can be related to prior antigenic
exposure in the population [1–3,28]; and that each inﬂuenza
pandemic last century was marked by a signature shift in
relative impact from older to younger age groups [24,25].
The purpose of this study was to evaluate the use of ED visit
data for monitoring the age-speciﬁc timing and impact of
epidemic inﬂuenza by predominant circulating viral type,
subtype, and antigenic strain. Using a broad deﬁnition of ED
visits classiﬁed as fever or respiratory syndrome chief
complaints, we applied a statistical method, routinely used
for monitoring clinical ILI [29,30] and P&I mortality data
[5,19,20], to ED surveillance data to monitor visits during
periods of inﬂuenza circulation and provide a surrogate
measure of incident inﬂuenza-attributable ED visits in NYC.
By quantifying and visualizing the temporal and age-speciﬁc
course of inﬂuenza morbidity in the context of available
laboratory surveillance data, we sought to improve ongoing
inﬂuenza surveillance efforts in NYC.
Methods
Emergency Department Surveillance Data
Electronic reporting of ED chief complaint data from NYC
hospitals occurred daily during the study period from mid-
November 2001 through June 2006. Data received each
morning were typically .90% complete for the preceding
day, and data received Monday mornings .95% complete for
the preceding week. During the 2001–2002 season participat-
ing hospital EDs captured an estimated 65% of all ED visits
citywide. Coverage gradually increased through the study
period, reaching 79% of all ED visits citywide during 2002–
2003, 88% during 2003–2004 and 90% during 2004–2005 and
2005–2006. Individual ED visit data were aggregated by age
group, chief complaint syndrome group, and week ending
Saturday.
Of the 13.3 million ED visits reported by participating NYC
facilities during the study period, 2.3 million were categorized
into a broad ‘‘fever and respiratory’’ syndrome composed of
the hierarchical and mutually exclusive syndromes ‘‘respira-
tory,’’ ‘‘fever/ﬂu,’’ ‘‘common cold,’’ and ‘‘sepsis,’’ as previously
described [6]. These syndromes have been used as part of
daily surveillance activities in NYC since 2001, and were
deﬁned as follows: The ‘‘sepsis’’ syndrome captured ED visits
whose chief complaint contained key words representing
sepsis, bacteremia, cardiac arrest, unresponsive, unconscious,
or dead on arrival—the sepsis syndrome was included to
capture visits with chief complaints describing potential,
severe inﬂuenza outcomes that would otherwise have been
missed. The ‘‘common cold’’ syndrome captured visits with
key words representing stuffy nose or nasal or cold symptoms
that were not in visits captured within sepsis. The ‘‘respira-
tory’’ syndrome captured visits with key words and Interna-
tional Classiﬁcation of Diseases 9th edition (ICD-9) codes
representing pneumonia, shortness of breath, bronchitis,
upper respiratory tract infection, difﬁculty breathing,
pleurisy, croup, cough, dyspnea, and chest cold, which were
not captured within the sepsis or common cold syndromes.
And the ‘‘fever/ﬂu’’ syndrome captured visits with key words
and ICD-9 codes representing fever, chills, malaise, body
aches, viral syndrome, and inﬂuenza, which were not
captured within the sepsis, common cold, or respiratory
categories, and did not include key words representing acute
gastroenteritis, enteritis, or diarrhea. While chief complaints
of ‘‘fever with diarrhea’’ could potentially be due to inﬂuenza,
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with coincident epidemic viral gastroenteritis.
The broad ‘‘fever and respiratory’’ syndrome category
described above was used to provide the most sensitive
measure of ED visits potentially attributable to inﬂuenza. We
also created a speciﬁc ‘‘ILI’’ syndrome following the
commonly used clinical surveillance deﬁnition of fever with
cough and/or sore throat: Of the 2.3 million visits categorized
into the broad fever and respiratory syndrome, 260,000 visits
were categorized as ILI, deﬁned as a chief complaint
composed of an inﬂuenza keyword or of a fever-related key
word with a mention of ‘‘cough’’ and/or ‘‘sore throat.’’ The
broad fever and respiratory and the narrow ILI syndrome
data are shown in Figure 1. ED visit data aggregated by age
into the groups , 2 y, 2–4 y, 5–12 y, 13–17 y, 18–29 y, 40–64 y
and   65 y, are shown for the broad fever and respiratory
group in Figure 2, and the narrow ILI group in Figure S1.
Laboratory Surveillance Data
Weekly counts of inﬂuenza A and B virus isolates were
reported during the study by three World Health Organ-
ization (WHO) collaborating laboratories located in NYC
(Figure 1). We used the viral isolate data to identify ‘‘inﬂuenza
circulation periods,’’ deﬁned as beginning the week when one
or more isolates were reported in two consecutive weeks
leading continuously into the seasonal epidemic period
(vertical lines in Figures 1, 2, S1, and S2) and ending when
the last isolate was reported each season. We deﬁned
predominant ‘‘inﬂuenza epidemic periods’’ as the consec-
utive upper quartile weeks of viral isolate reporting during
the ﬁve inﬂuenza seasons in the study: these were simply the
worst 25% of weeks, or the 61 weeks reporting the greatest
number of viral isolates during the 244-wk study period.
National and mid-Atlantic regional inﬂuenza subtype and
antigenic strain surveillance data reported by CDC [5] were
used to infer likely dominant strains circulating during each
period of inﬂuenza activity in the city (Table 1).
Hospitalization and Death Data
Conﬁrmed hospitalizations by admission date in NYC from
1997–1998 to 2004–2005 were analyzed by multiple cause
ICD-9 code reports for inﬂuenza (487), P&I (480–487), and
respiratory syncytial virus (RSV) (079.6, 466.11) [22,23].
Conﬁrmed deaths from 1997–1998 to 2003–2004 were
analyzed as all-cause and by reported primary cause of death
code for P&I (ICD-9 480–487; ICD-10 J10.0–J11.8, J12.0–J18.9)
[20,21]. The hospitalization and death data for 1997–1998
through 2000–2001 are shown for comparison (Figure 3).
Data were aggregated by week ending Saturday, and by , 65 y
and   65 y age groups.
Figure 1. Weekly Influenza Isolates and ED Fever and Respiratory and ILI Visits in New York City during the 2001–2002 to 2005–2006 Seasons
Dates are CDC year and week ending Saturday. Top graph, isolates by influenza type are from WHO collaborating laboratories, with subtype and strain
designation based on predominant regional and national antigenic lineage: A/H3-SY, predominant circulating A(H3N2) Sydney-lineage viruses; B/VI,
predominant circulating B/Victoria-lineage; A/H1, either A(H1N1) New Caledonia- or A(H1N2) Wisconsin-lineage; A/H3-FU, A(H3N2) Fujian-lineage; B/YA,
B/Yamagata-lineage; and A/H3-CA, A(H3N2) California-lineage. Middle and bottom graphs, observed fever and respiratory syndrome (middle) and ILI
syndrome (bottom) ED visits are shown as black lines, and seasonally expected Serfling baseline visits as red lines. Dashed lines represent epidemic
thresholds as model estimates plus two standard deviations. Shaded areas represent estimated influenza-attributable excess ED visits: blue areas
correspond to periods of increasing and dominant influenza A circulation and red areas to influenza B. Vertical lines indicate the first week of
continuous influenza isolate reporting each season.
doi:10.1371/journal.pmed.0040247.g001
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Weekly counts of ED visits coded by chief complaint into
the broad fever and respiratory syndrome and the narrow ILI
syndrome categories followed annual sinusoidal patterns of
winter seasonal increase, punctuated by seven distinct
periods of 6–12 wk duration coincident with positive
inﬂuenza A or B isolate reporting by WHO collaborating
laboratories in the city (Figure 1). Weekly counts of P&I
hospitalizations from 1997 to 2005 and deaths from 1997 to
2004 similarly followed a pattern of winter-seasonal increase,
punctuated by inﬂuenza A/H3N2 epidemics (Figure 3). To
estimate the number of ED visits, hospitalizations, and deaths
attributable to inﬂuenza we used a traditional Serﬂing
regression approach [5,19,20,29,30] applied to the weekly
time series of ED visits, hospitalizations, and deaths, censor-
ing inﬂuenza epidemic periods before ﬁtting the model. To
calculate expected ED visits for each group we used the
equation
Mt ¼ a0 þ a1t þ c1cos(2pt/52.18) þ d1sin(2pt/52.18)
þ c2cos(4pt/52.18) þ d2sin(4pt/52.18) þ et.
Our estimates of expected ED visits by age and syndrome
group during week t( M t) were derived from least squares
regression of the observed data by group using a constant a0,
secular trend a1, annual sinusoidal terms c1 and d1, semi-
annual terms c2 and d2, and an error term et, applied to
noncensored weeks. Estimates of excess weekly ED visits were
calculated as observed minus expected. Our signiﬁcance level,
or ‘‘epidemic threshold,’’ was arbitrarily set at two standard
deviations above the expected, as derived from the model
variance of nonepidemic weeks. We applied the seasonal
model and threshold to all weekly ED visit, hospitalization,
and death time series.
Estimates of excess seasonal epidemic ED visits were
calculated as observed minus expected visits during inﬂuenza
epidemic periods and consecutive weeks adjacent to those
periods when the observed was above expected (shaded areas,
Figure 1; Table 1). The nonadjacent periods of signiﬁcant (i.e.,
over two standard deviations above Serﬂing baseline) excess
ED visits occurring outside of inﬂuenza circulation periods
were assumed not to be inﬂuenza-attributable and are
considered separately, below. Our estimates of total citywide
excess ED visits were extrapolated based on the proportion of
ED visits citywide that were captured each season by
participating hospitals in the surveillance system. Total
citywide inﬂuenza season excess ED visit rates were calculated
based on year 2000 age-speciﬁc US Census data for NYC
(Table 1).
To better understand age-speciﬁc visit patterns that
occurred during periods of sporadic or no inﬂuenza
circulation, we evaluated the timing and impact of two
additional causes of seasonal respiratory illness: RSV and tree
pollen. We identiﬁed predominant RSV periods as the upper
quartile weeks of RSV hospitalizations from 2001 to mid-
December 2005 (data shown in Figure S2) and predominant
seasonal tree pollen periods as the 4 wk of greatest tree pollen
counts recorded in 2005 and 2006 from a single environ-
mental monitoring site in NYC.
Estimating Epidemic Timing
We deﬁned initial detection of annual inﬂuenza epidemics
as the ﬁrst week ED visits, hospitalizations or deaths exceeded
the two-standard-deviation threshold above model baseline.
We compared the date of initial detection based on ED visits,
hospitalizations, and deaths by age group (Table S1). We
additionally evaluated age-speciﬁc epidemic timing by cross
correlation [7], restricting our analysis to the 33-wk window
centered on the viral inﬂuenza isolate peaks each season. We
calculated Pearson cross-correlation coefﬁcients with lags.
Figure 2. Weekly Age-Specific Fever and Respiratory ED Visits in New
York City during the 2001–2002 to 2005–2006 Seasons
Observed fever and respiratory ED visits by age group are shown as black
lines, and seasonally expected Serfling baseline visits are as red lines.
Dashed lines represent model estimates plus two standard deviations.
Shaded areas represent influenza-attributable excess ED visits by type A
(blue) or B (red). Vertical lines indicate the first week of continuous
influenza isolate reporting. Codes in top graph: A/H3-SY, influenza
A(H3N2) Sydney; B/VI, influenza B/Victoria; A/H1, either A(H1N1) New
Caledonia or A(H1N2) Wisconsin; A/H3-FU, influenza A(H3N2) Fujian; B/
YA, influenza B/Yamagata; and A/H3-CA, influenza A(H3N2) California.
doi:10.1371/journal.pmed.0040247.g002
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single week coefﬁcient, or with similar consecutive week
coefﬁcients, as providing the best estimated measure of
inherent epidemic timing relative to inﬂuenza isolates. We
evaluated age-speciﬁc epidemic timing for ED visits, hospital-
izations, and deaths for 2003–2004, the only inﬂuenza season
in our study with available data and with signiﬁcant excess ED
visits, hospitalizations, and deaths across age groups (Figure
4).
Visualization of Morbidity by Age
To visualize the temporal course of age-speciﬁc illness
trends in NYC, fever and respiratory ED visits were
detrended, normalized, and plotted by week and age group.
To detrend the data, we ﬁt a least-squares linear regression to
the nonepidemic fever and respiratory ED visit data by age
group, as above, but with the annual and semiannual seasonal
sinusoidal terms removed. We divided the observed data time
series by the nonepidemic linear ﬁt to obtain normalized ED
visits by week and category. We made a surface plot of
normalized weekly time series as a gradient interpolated
between adjacent week and age-group data points (Figure 5).
Inﬂuenza epidemic periods, based on WHO collaborating
laboratory isolate reports in NYC, from 2001–2002 to 2005–
2006 were shown above each seasonal plot, and seasonal RSV
predominant periods were shown as the upper quartile weeks
of RSV hospitalizations from 2001 through 2005, based on the
available data for all ICD-9 coded hospitalizations in NYC
(Figures 5 and S2). Dominant tree pollen periods, based on
available data from a single monitoring site in NYC, were
shown above the spring 2005 and 2006 plots (Figure 5).
Results
Seasonal Impact
From the 2001–2002 to 2005–2006 inﬂuenza seasons in
NYC, we estimate on average that 40,000 excess ED visits (5.0
visits per 1,000 population) occurred per season during the
documented inﬂuenza circulation periods. We estimate that
2,800 excess P&I hospitalizations (0.35 per 1,000) on average
occurred per season from 2001–2002 to 2004–2005, and 500
excess all-cause (0.065 per 1,000) and 100 excess P&I (0.012
per 1,000) deaths occurred per season from 2001–2002 to
2003–2004. The seasonal impact of excess ED visits, hospital-
izations, and deaths, however, varied greatly by age group and
circulating virus. We summarize our results by season and
predominant viral period.
2001–2002 season: An estimated 24,000 excess fever and
respiratory ED visits (3.0 visits per 1,000 population), 2,200
excess P&I hospitalizations (0.28 per 1,000), 540 excess all-
cause deaths (0.067 per 1,000), and 90 excess P&I deaths (0.011
per 1,000) occurred during the inﬂuenza A/H3N2 predom-
inant period in NYC from December 2001 to February 2002
(weeks 50–07) (Figures 1–3; Table 1). An estimated 17,000
excess ED visits (2.1 per 1,000) occurred during the inﬂuenza
B/Victoria predominant period from February to April 2006
(weeks 08–13) (Figure 1; Table 1). Excess ED visits during the
inﬂuenza B/Victoria-period were most notably increased
among school-aged children (aged 5–12 y and 13–17 y), with
no detected increase among adults (Figures 2 and 5; Table 1).
There were no excess P&I hospitalizations or deaths detected
during the inﬂuenza B period this season (Figure 3).
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Monitoring the Impact of Influenza by Age2002–2003 season: An estimated 10,000 excess ED visits (1.2
per 1,000 population) occurred during the predominant
inﬂuenza A/H1 period (Figure 1; Table 1), with excess visits
detected only among preschool (2–4 y) and school-aged (5–12
y and 13–17 y) children, and adults aged 18–39 y (Figure 2).
Visits among children age , 2 y and 2–4 y were increased
during autumn and early winter (weeks 45–01) prior to the
inﬂuenza epidemic period (weeks 03–09). The autumn and
early winter timing of ED visit increases among children age
,2 y and 2–4 y (weeks 45–01) coincided with the retro-
spectively identiﬁed period of predominant RSV hospital-
izations (Figures 2 and S2). An estimated 370 excess all-cause
deaths (0.047 per 1,000), and few excess P&I hospitalizations
or deaths, were detected during this season (Figure 3; Table
1).
2003–2004 season: An estimated 71,000 excess fever and
respiratory ED visits (8.9 per 1,000 population) occurred
during the inﬂuenza A/H3N2 predominant period from
November 2003 to January 2004 (weeks 46–01) (Figure 1;
Table 1). Excess ED visits were detected across age groups
(Table 1), with the highest rates occurring among children age
,2 y (Figures 2 and 5; Table 1). An estimated 4,400 excess P&I
hospitalizations (0.55 per 1,000), 640 excess all-cause deaths
(0.080 per 1,000), and 190 excess P&I deaths (0.023 per 1,000)
occurred this season (Figure 3; Table 1).
2004–2005 season: An estimated 42,000 excess fever and
respiratory ED visits (5.2 per 1,000 population) and 3,600
excess P&I hospitalizations (0.44 per 1,000) occurred during
the inﬂuenza A/H3N2 predominant period from November
2004 through January 2005 (weeks 46–04) (Figures 1 and 3;
Figure 3. Weekly P&I Hospitalizations and All-Cause and P&I Deaths in New York City
Observed P&I hospitalizations by age group from 1998–1999 to 2004–2005, and deaths for all ages from 1998–1999 to 2003–2004, are shown as black
lines. Seasonally expected Serfling baseline levels are shown as red lines, and two-standard-deviation thresholds are shown as dashed lines.
Catastrophic event deaths were removed from the data, and heat-wave period deaths were censored from the Serfling analysis. Observed P&I deaths
during the 1999–2000 season were low due to a changeover from ICD-9 to ICD-10 coding. Codes in top graph: A/H3-SY, influenza A(H3N2) Sydney; B/VI,
influenza B/Victoria; A/H1, either A(H1N1) New Caledonia or A(H1N2) Wisconsin; A/H3-FU, influenza A(H3N2) Fujian; B/YA, influenza B/Yamagata; andA /
H3-CA, influenza A(H3N2) California.
doi:10.1371/journal.pmed.0040247.g003
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Monitoring the Impact of Influenza by AgeTable 1). An estimated 22,000 excess ED visits (2.7 per 1,000)
occurred during the period of inﬂuenza B predominance and
sporadic inﬂuenza A circulation from February to April 2005
(weeks 05–14) (Table 1). Excess ED visits were increased across
all age groups during the inﬂuenza A-predominant period
(Figures 1 and 2). Compared to the 2003–2004 epidemic, the
relative impact during the corresponding A/H3N2 epidemic
weeks in 2004–2005 was shifted toward older age groups: the
proportion of total excess fever and respiratory ED visits
among those   65 y went from 6% in 2003–2004 to 13% in
2004–2005, and the proportion of total excess P&I hospital-
izations among those   65 y went from 45% in 2003–2004 to
69% in 2004–2005 (Figure 2; Table 1).
2005–2006 season: An estimated 12,000 excess ED visits (1.5
per 1,000 population) occurred during the inﬂuenza A/H3N2
predominant period, with excess ED visits detected in the age
groups 2–4 y, 5–12 y, 13–17 y, 18–39 y, and 40–64 y (Figure 2;
Table 1). Fever and respiratory ED visits peaked in the , 2y
age group prior to the beginning of the identiﬁed inﬂuenza
epidemic period and more than 4 wk before the peak in
inﬂuenza isolate data (Figure 2).
Epidemic Timing
Inﬂuenza epidemic period increases were seen earlier in
ED visits than in hospitalizations or deaths. During the
inﬂuenza A/H3N2 epidemics in 2001–2002 and 2003–2004,
excess all-ages fever and respiratory ED visits exceeded our
two-standard-deviation Serﬂing model threshold 1 wk prior
to P&I hospitalizations and, respectively, 1 and 3 wk prior to
P&I deaths. During the mild inﬂuenza A/H1 epidemic in
2002–2003, all-ages fever and respiratory ED visits exceeded
threshold 2 wk prior to deaths, and in the A/H3N2 epidemic
in 2004–2005, all-ages ED visits exceeded threshold 3 wk prior
to P&I hospitalizations (Figures 1 and 3; Table S1).
Fever and respiratory ED visits among children often
exceeded threshold before adults, but there were differences
between seasons. During 2001–2002, ED visits exceeded
model thresholds in the , 2 y and 2–4 y age groups 1 wk
before the 13–17 y and 18–39 y age groups, and 2 wk before
the 5–12 y and 40–64 y age groups. During the more severe
2003–2004 A/H3N2 epidemic, age-speciﬁc ED visits exceeded
threshold in the 13–17 y age group 1 wk before the , 2y ,2 – 4
y, 5–12 y, and 18–39 y groups, 3 wk before the 40–64 y group,
and 4 wk before the   65 y group (Figure 2; Table S1). During
the 2004–2005 inﬂuenza A/H3N2 epidemic, age-speciﬁc ED
visits exceeded model threshold in the 2–4 y, 5–12 y, and 13–
17 y age groups 1 wk prior to the , 2 y, 18–39 y, 40–64 y, and
  65 y age groups (Figure 2; Table S1). The threshold level was
arbitrary, with the measure of timing reﬂecting noninﬂuenza
period variance and not necessarily inherent epidemic
timing.
In our estimation of inherent epidemic timing, we limited
our analysis to the 2003–2004 season, since it was the most
severe and the only one with available ED, hospitalization,
and death data and signiﬁcant excess estimates across age
groups (Figures 1–3). Our lagged cross-correlation analysis of
excess ED visits, hospitalizations, and deaths compared
against viral inﬂuenza surveillance data found the greatest
cross-correlation coefﬁcients occurred when P&I deaths
lagged viral data by 2 wk, and P&I hospitalizations and ED
visits coincided with viral data, although the leading cross-
correlation coefﬁcients for ED visits were greater than for
Figure 4. Epidemic Weekly Lead or Lag Cross-Correlation during the
2003–2004 Influenza A/Fujian Season in New York City
Excess fever and respiratory ED visits and P&I hospitalizations and deaths
were correlated against influenza isolates during the 33 wk centered on
peak isolates. Top, maximum cross-correlation values for ED visits and
hospitalizations coincided with influenza isolates (no lag) with ED visits
leading hospitalizations, by less than 1 wk. Maximum correlation values
for P&I deaths lagged isolates by 2 wk. Middle, maximum correlation
values for 2–4 y, 5–12 y, and 13–17 y ED visits led isolates by 1 wk, , 2y ,
18–39 y, and 40–64 y visits had no lag, and   65 y visits lagged isolates
by 1 wk. Bottom, maximum cross-correlation values for , 65 y P&I
hospitalizations had no lag, for   65 y hospitalizations and , 65 y P&I
deaths had a 1 wk lag, and for   65 y P&I deaths had a 3 wk lag.
doi:10.1371/journal.pmed.0040247.g004
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Monitoring the Impact of Influenza by AgeFigure 5. Observed Fever and Respiratory ED Visit Surface Plots by Age Group in New York City during the 2001–2002 to 2005–2006 Influenza Seasons
Each season is shown from early September through mid-June by CDC week and year. Weeks of predominant influenza A (blue bar) or B (red bar)
isolate surveillance during the study period, retrospectively identified predominant RSV hospitalizations through 2005 (gray bar), and dominant tree
pollen periods for 2005 and 2006 (green bar) are shown above each season. Weekly ED visits by age group were detrended and normalized: age-specific
intensity is shown as a color gradient interpolated between data points, with observed visits ranging from 2 to .4 times mean noninfluenza levels
during peak epidemic weeks, and 0.25 to 1.25 during nonepidemic periods. Visits were increased across all age groups during periods of influenza A/
H3N2 predominance, and were most markedly increased during the 2003–2004 and 2004–2005 A/Fujian-lineage epidemics. Visit increases during
periods of influenza A/H1 and B predominance impacted preschool (2–4 y) and school-aged (5–17 y) children, and were most dramatically elevated
during the B/Victoria-lineage reemergence in early 2002. The autumn and early-winter predominance of RSV preceded influenza in 2001, 2002, and
2005, and coincided with increased visits in the , 2 y and 2–4 y age groups. Visits were notably increased among school-aged children and working-
aged adults during the dominant tree pollen period in 2006. RSV hospitalization data were not available for 2006 (*), and viral influenza surveillance
reporting was incomplete during weeks 12 to 16, 2006 (*).
doi:10.1371/journal.pmed.0040247.g005
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Monitoring the Impact of Influenza by Agehospitalizations (Figure 4, top). The maximum cross-correla-
tion coefﬁcient for viral isolates and excess ED fever and
respiratory visits by age found school-aged children (5–12 y
and 13–17 y) leading viral isolates by 1 wk, preschool-aged
children (2–4 y) leading viral isolates by 1 wk although lagging
school-aged children slightly, younger children (,2 y) and
working-aged adults (18–39 y and 40–64 y) roughly coinciding
with viral isolates, and older adults ( 65 y) lagging viral
isolates by 1 wk (Figure 4, middle). The maximum cross-
correlation coefﬁcient for P&I hospitalizations and deaths by
age group found , 65 y hospitalizations coinciding with viral
isolates,   65 y hospitalizations and , 65 y P&I deaths lagging
viral isolates by 1 wk, and   65 y deaths lagging viral isolates
by 3 wk (Figure 4, bottom).
Visualizing Age-Specific Morbidity Patterns
Observed fever and respiratory ED visits peaked annually
during inﬂuenza epidemic periods as deﬁned by laboratory
evidence (Figure 1). The age pattern of observed and
normalized visits varied by season and circulating virus
(Figures 2 and 5). Each autumn, increased visits were seen
among children aged , 2ya n d2 – 4yd u r i n gR S V -
predominant periods, and were notably elevated between
autumn and early-winter (weeks 48–01), regardless of whether
inﬂuenza circulation was detected (Figure 5): for example,
seasonal fever and respiratory ED visit peaks in the , 2 y age
group occurred during week 52 in 2002–2003 and 2005–2006,
prior to the beginning of the deﬁned inﬂuenza epidemic
period and well before viral inﬂuenza isolates and older-age
group ED visits peaked (Figures 2 and 5). Otherwise, during
each inﬂuenza epidemic period in our study, fever and
respiratory ED visits peaked earliest in school-aged children.
The ED visit peaks in the 5–12 y and 13–17 y age groups
during the two most severe seasons, 2003–2004 and 2004–
2005, immediately preceded the end-of-year winter holiday
school breaks.
The more speciﬁc subset of ILI ED visits, with mention of
inﬂuenza or co-occurrence of fever with cough and/or sore
throat, constituted only 11% of the broader fever and
respiratory category (Figure 1), however the two trends were
highly correlated (r
2 ¼ 0.96, p , 0.001). Exceptions included
tree pollen-dominant periods in spring 2005 and 2006 when
the broad fever and respiratory category of ED visits saw
increases among school-aged children and working-aged
adults (5–12 y, 13–17 y, 18–39 y, and 40–64 y) (Figure 5), with
no corresponding increase in the more speciﬁc ILI category
(Figures 2 and S1).
Discussion
In our analysis of New York City ED data, we found that
predominant increases in fever and respiratory visits corre-
sponded in timing and magnitude with laboratory-conﬁrmed
inﬂuenza, and we suggest that our estimates of excess ED
visits provide a reliable surrogate measure of the incident
impact attributable to inﬂuenza. By applying standard
statistical methods to electronic ED chief complaint data,
and interpreting results in the context of available informa-
tion about circulating viruses, we were able to evaluate and
track age-speciﬁc inﬂuenza morbidity in greater detail than
was previously possible in NYC. We found the burden of
excess ED visits was greatest during peak inﬂuenza periods,
disproportionately impacted children, often impacted chil-
dren earliest, generally coincided in timing with P&I
hospitalization admission data, and preceded P&I death data
by roughly 1–2 wk. The age-speciﬁc pattern of excess ED visits
varied depending on the predominant circulating viral type,
subtype, and strain. We expand on these ﬁndings below.
Reemergence of B/Victoria-Lineage Influenza, 2001–2002
Beginning the week ending February 16, 2002 (week 06–
2002), a marked and sustained increase in ED fever and
respiratory visits began in NYC that predominated among
school-aged children (5–17 y). In the US, inﬂuenza B/Victoria-
lineage viruses had last been widespread 13 y prior, during
1988–1989 in a mixed inﬂuenza B and A/H1N1 season, and
had last been the predominant epidemic virus 16 y earlier,
during the 1985–1986 season [23,31,32]. This pattern would
suggest that in 2002, children age 13–16 y had minimal prior
exposure, and children age 12 y and under had very little or
no opportunity for prior exposure to this inﬂuenza B
antigenic lineage, consistent with observed excess fever and
respiratory (Figure 2) and ILI (Figure S1) ED visits. Local
clinical and outbreak reports later noted the unusual age-
speciﬁc impact of these B/Victoria viruses elsewhere in the US
[33,34], and school absenteeism and ED surveillance in NYC
were noted to have signaled signiﬁcant increases during the
epidemic [6,35]. However, ongoing morbidity surveillance at
the time did not detect or characterize the impact [5,6], and
no comment was made connecting previous circulation of
this antigenic lineage with the age-speciﬁc groups at risk. A
greater awareness of the event through routine monitoring of
age-speciﬁc illness data could have informed physicians and
public health ofﬁcials that an inﬂuenza virus antigenically
novel to children age 12 y and under was epidemic.
Epidemic A/H3N2 Fujian-Lineage Influenza
Antigenic variant inﬂuenza A/H3N2 Fujian-lineage viruses
emerged in autumn 2003 and were widespread across the US
by the beginning of winter. The 2003–2004 seasonal inﬂuenza
v a c c i n ew a sr e p o r t e dt ob ep o o r l ym a t c h e dw i t ht h e
circulating A/Fujian viruses [5]. Our analysis of fever and
respiratory ED visits indicated that the epidemic impact on
morbidity was signiﬁcant across all age groups, though
greater among children (Figure 2; Table 1) and with a distinct
within-season age shift (Figure 4). Our analysis of the timing
of ED visits indicates that the course of the epidemic
progressed in a cascading fashion from primary school (5–
17 y), to preschool (2–4 y), to younger children and working-
age adults (,2 y and 18–64 y), to older adults ( 65 y) (Figure
4). Our analysis of ED visits and P&I hospitalizations and
deaths indicates that the morbidity impact seen in ED visits
and hospitalizations preceded the impact seen in deaths by 1–
2 wk, with P&I hospitalizations and deaths following a similar
age-stratiﬁed progression from younger (,65 y) to older ( 65
y) ages (Figure 4).
In autumn 2004, inﬂuenza viruses reported to be antigeni-
cally A/Fujian-like [5] reemerged and were epidemic in NYC.
The pattern and age distribution of morbidity in 2004–2005
presented a distinct shift in impact compared to 2003–2004,
in both ED fever and respiratory and ILI visits (Figures 2 and
S1) and P&I hospitalizations (Figure 3). The relative impact in
children and younger adults was greater during the ﬁrst
reported circulation of A/Fujian-lineage viruses in NYC, while
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Monitoring the Impact of Influenza by Agethe relative impact in older adults was greater during the
second (Table 1). It is not known if the age shift from 2003–
2004 to 2004–2005 was due to genetic or antigenic differences
in the circulating viruses, or to age-speciﬁc cohort effects in
transmission and impact. It is also not known whether this
interpandemic period shift was similar in character to the
shift in impact to older adults seen in the successive seasons
following primary pandemic waves in the last century [1,24].
Seasonal RSV
While RSV surveillance data were not available during the
study period, coded hospitalizations allowed us to retro-
spectively identify predominant RSV periods in NYC (Figure
S2). The impact of RSV hospitalizations during the 2001–
2002, 2002–2003, and 2005–2006 seasons occurred prior to
the beginning of the inﬂuenza epidemic periods (Figure 5).
During these seasons, increases in fever and respiratory ED
visits occurred in the age groups , 5 y before documented
inﬂuenza circulation began. Across all seasons the course of
fever and respiratory ED visits in young children increased by
mid-November, regardless of the timing or impact of
inﬂuenza. The absence of a signiﬁcant increase in ED visits
among school-aged children or adults during these periods
was consistent with RSV only modestly impacting older ages,
and suggests that estimates of severe excess RSV-attributable
mortality in older individuals [23] be reevaluated [36–38]. The
age-speciﬁc impact on morbidity from RSV and other
respiratory infections such as metapneumovirus [39] or novel
rhinoviruses [40], should be considered when evaluating fever
and respiratory morbidity surveillance and should be studied
further.
Spring Tree Pollenosis
In NYC we have consistently observed increases in ED
respiratory and asthma visits outside of inﬂuenza season
during the spring and early fall. The impact seen each spring
is often severe enough to affect any syndrome that includes
respiratory chief complaints, but is not associated with an
increase in febrile illness. Pollen data obtained for the spring
of 2005 and 2006 show that increases apparent in the broad
fever and respiratory syndrome group among patients aged
5–64 y were coincident with the predominant annual tree
pollen release (Figures 2 and 5). A similar pattern of
respiratory and asthma exacerbations associated with tree
and grass pollenosis has recently been reported [41], and the
age-speciﬁc pattern of morbidity due to cedar tree pollenosis
has been well described in Japan [42].
Influenza Timing
In our analysis, we found that increases in inﬂuenza-
attributable ED visits preceded hospitalizations, which in turn
preceded deaths (corresponding to the logical progression of
illness). During the 2003–2004 A/Fujian epidemic season we
found fever and respiratory ED visits and P&I hospitalizations
and deaths strongly correlated with viral isolate data, with an
optimum lag between ED visits and deaths on the order of 2–
3 wk (Figure 4, top). Our age-speciﬁc analysis of this epidemic
found ED visits by age strongly correlated with viral data, with
the greatest lag found between the 5–17 y and  65 y age
groups on the order of 2 wk, with younger children and
working-age adults in between (Figure 4, middle). The time
series of P&I hospitalizations by age group were strongly
correlated with viral data, with a lag between , 65 y and   65
y hospitalizations on the order of 1 wk (Figure 4, bottom). The
time series of P&I deaths by age group were most strongly
correlated with a lag between , 65 y and   65 y deaths on the
order of 2 wk. While we found no strict temporal age pattern
across seasons, we did ﬁnd late autumn increases in ED fever
and respiratory visits among children age , 5 y regardless of
inﬂuenza circulation (and coincident with predominant
RSV), and we found that inﬂuenza epidemic period peaks
occurred earliest among school-aged children each season
regardless of circulating inﬂuenza viral type, subtype or
strain.
A study of Boston area ED surveillance data reported that
ED respiratory visits increased ﬁrst among preschool age
children (aged 3–4 y), some 5–7 wk before ED visits among
older persons [8]. This ﬁnding may have been be due to the
impact of RSV, and to the use of aggregate interseasonal
waves masking within-season variation by age. Analysis of the
period from 2001 to 2006 using these methods on NYC ED
visit data would show the age-speciﬁc impact of RSV shifting
the overall timing of , 5 y ED visits earlier, while the spring
inﬂuenza B/Victoria epidemic would shift 5–17 y ED visits
later. Aggregate interseasonal time series analysis can be valid
for seasonal inﬂuenza mortality, where a single wave of
mortality predominates each season. Assessment of aggre-
gated seasonal time series of ILI, fever, or respiratory
morbidity data, where multiple etiologically distinct within-
season waves are common, however, must be done with
caution and at the appropriate scale [43].
Influenza Impact
While the burden of inﬂuenza-attributable hospitalizations
and deaths occurred predominantly among older adults, the
burden of inﬂuenza-attributable excess fever and respiratory
visits to NYC EDs during our study was predominantly among
children (Figure 2; Table 1). Our estimated NYC-wide
inﬂuenza attributable ED visit rates among young children
(aged ,5 y), during the 2003–2004 A/H3N2-Fujian epidemic,
were greater than the ED visit rate estimates reported by
Poehling and colleagues [44], and less than their outpatient
clinic estimates, possibly reﬂecting greater utilization of EDs
for pediatric primary care in NYC. While the overall impact
from inﬂuenza during the study period was moderate
compared to preceding A/H3N2 Sydney-lineage epidemic
seasons (Figure 3), the impact seen in NYC EDs was
nonetheless considerable and varied. For each estimated
excess P&I death we found during the 2003–2004 A/Fujian
epidemic, there were approximately 3.5 excess all-cause
deaths, 24 excess P&I hospitalizations, and 390 excess fever
and respiratory ED visits in NYC.
Our study had several limitations. First, estimating inﬂu-
enza-attributable morbidity and mortality is imperfect due to
the nonspeciﬁc nature of inﬂuenza symptoms and the lack of
laboratory conﬁrmation for the vast majority of inﬂuenza
cases [1]. We considered excess visits as primarily attributable
to inﬂuenza when they occurred during periods of virally
conﬁrmed inﬂuenza circulation, but some of the fever and
respiratory syndrome visits outside of these periods were
likely due to inﬂuenza infection, and to some extent excess
visits during inﬂuenza periods could clearly be due to
coincidentally circulating viruses. Furthermore, the free-text
chief complaints used to categorize ED visits into syndrome
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Monitoring the Impact of Influenza by Agegroups are imprecise indicators of illness, and many
inﬂuenza-attributable visits may have been missed. We also
did not explicitly consider the inﬂuence of ED utilization on
age-speciﬁc visit rates. For example, parents may be more
likely to bring a young child to the ED for an evaluation of
inﬂuenza-like illness than to visit the ED themselves. A
greater proportion of younger patients with acute inﬂuenza
infection may have had fever with respiratory symptoms and
been captured in our syndrome deﬁnition, while older
patients with inﬂuenza-attributable illness and complications
may have presented later and with a broader range of
complaints, many of which might not have been captured by
our syndrome coding. Finally, we had only 5 y of data
covering a unique, large, and dense urban population, and
our ﬁndings may not be generalizable to other years or to
other regions. Within the context of these limitations, our
results highlight the fact that each inﬂuenza season and
epidemic period is unique in its age-speciﬁc timing,
progression, and impact.
The reliance of researchers on hospitalization and death
data, and the difﬁculty of obtaining population-based and
age-detailed estimates of morbidity have contributed to the
misconception that inﬂuenza affects only the very young and
the very old. While the burden of severe morbidity and
mortality occurs at the extremes of age, our ﬁndings support
the observation that school-aged children experience early
and high attack rates and exhibit signiﬁcant morbidity,
supporting evidence that they play an important role in
communitywide transmission [16–18]. Vaccination of school-
aged children has been suggested to provide both direct
protection for those vaccinated and indirect protection for
unvaccinated age groups within the population during
interpandemic [45] as well as pandemic periods [13]. The
early and speciﬁc increases in fever and respiratory ED visits
that we observed among children during the ﬁrst season of A/
H3N2 Fujian circulation are consistent with other studies
showing that epidemic inﬂuenza strains may circulate and
amplify ﬁrst among children before spreading to older age
groups [16–18]. These ﬁndings may have implications for
targeted nonpharmaceutical intervention, antiviral, and
vaccination strategies, and lend support for broadening the
age categories recommended for routine and pandemic
vaccination.
Twentieth-century inﬂuenza can inform twenty-ﬁrst-cen-
tury surveillance. The experience with pandemic inﬂuenza in
the last century in New York City illustrates that early waves,
multiple waves, and within- and between-season age shifts in
morbidity and mortality can occur [46–48]. While the timing
and age-speciﬁc impact in the next pandemic cannot
currently be predicted, experience during the last ﬁve seasons
in New York City suggests that age-stratiﬁed ED surveillance
can provide a timely surrogate measure of morbidity that can
be used to monitor and describe the age-speciﬁc epidemiol-
ogy of inﬂuenza. Recent analyses of the 1918 pandemic in US
cities have shown that even transitory and imperfect public
health intervention strategies, when initiated early enough,
were partially beneﬁcial [49,50]. While our study does not
identify surveillance triggers for public health intervention or
address control measure efﬁcacy, our data do show that near-
time monitoring is feasible. Our results highlight the fact that
inﬂuenza epidemics can differ in timing, progression, and
impact by age. The integration of detailed and rapid
morbidity surveillance data, such as we have presented, with
viral, antigenic, and whole-genome analysis [51–54], may
improve our understanding of the complex dynamics of
inﬂuenza [55], and provide better opportunity for informed
and successful public health responses in the future.
Supporting Information
Figure S1. Weekly Age-Speciﬁc ILI Visits to the ED in New York City
during the 2001–2002 to 2005–2006 Seasons
Observed ILI syndrome ED visits by age group are shown as black
lines, and seasonally expected Serﬂing baseline visits as red lines.
Dashed lines represent epidemic thresholds as model estimates plus
two-standard deviations. Shaded areas represent estimated inﬂuenza
attributable excess ED visits: blue areas correspond to periods of
increasing and dominant inﬂuenza A circulation and red areas to
inﬂuenza B. Vertical lines indicate the ﬁrst week of continuous
inﬂuenza isolate reporting each season.
Found at doi:10.1371/journal.pmed.0040247.sg001 (249 KB PDF).
Figure S2. Weekly Inﬂuenza Viral Isolate Surveillance and RSV
Hospitalizations in New York City during the 2001–2002 to 2005–
2006 Seasons
Vertical lines indicate the ﬁrst week of continuous inﬂuenza virus
isolate reporting, viral isolate surveillance is indicated as in Figure 1.
The dashed horizontal lines indicate the level of inﬂuenza viral isolate
and RSV hospitalization upper quartile weeks.
Found at doi:10.1371/journal.pmed.0040247.sg002 (172 KB PDF).
Table S1. Summary of Consecutive Weeks of Inﬂuenza Circulation
Reporting, Epidemic Inﬂuenza Isolate Reporting, Epidemic Fever and
Respiratory ED Visits, and Epidemic P&I Hospitalizations and Deaths
in New York City during the 2001–2002 to 2005–2006 Seasons
Inﬂuenza isolate circulation dates are the CDC weeks from the ﬁrst
inﬂuenza isolate reported in continuous weeks (vertical lines in
Figures 1, 2, S1, and S2), through the last week reporting an inﬂuenza
isolate that season. Inﬂuenza epidemic weeks represent the upper
quartile weeks of inﬂuenza isolate reporting (ie the worst 25% of
weeks, shown in Figure 5). Epidemic fever and respiratory ED visits
(Figures 1 and 2), and P&I hospitalizations and deaths (Figure 3)
indicate the continuous weeks exceeding a two-standard-deviation
threshold above each Serﬂing baseline during the periods of
inﬂuenza circulation. Asterisks indicate continuous weeks that
exceeded threshold prior to the beginning of the inﬂuenza viral
isolate epidemic weeks. Dashes indicate seasons and groups where
there were no continuous weeks exceeding threshold. Empty cells
indicate no available data.
Found at doi:10.1371/journal.pmed.0040247.st001 (36 KB DOC).
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Background. Seasonal outbreaks (epidemics) of influenza (a viral
infection of the nose, throat, and airways) send millions of people to
their beds every winter. Most recover quickly, but flu epidemics often
disrupt daily life and can cause many deaths. Seasonal epidemics occur
because influenza viruses continually make small changes to the viral
proteins (antigens) that the human immune system recognizes.
Consequently, an immune response that combats influenza one year
may provide partial or no protection the following year. Occasionally, an
influenza virus with large antigenic changes emerges that triggers an
influenza pandemic, or global epidemic. To help prepare for both
seasonal epidemics and pandemics, public-health officials monitor
influenza-related illness and death, investigate unusual outbreaks of
respiratory diseases, and characterize circulating strains of the influenza
virus. While traditional influenza-related illness surveillance systems rely
on relatively slow voluntary clinician reporting of cases with influenza-
like illness symptoms, some jurisdictions have also started to use
‘‘syndromic’’ surveillance systems. These use electronic health-related
data rather than clinical impression to track illness in the community. For
example, increased visits to emergency departments for fever or
respiratory (breathing) problems can provide an early warning of an
influenza outbreak.
Why Was This Study Done? Rapid illness surveillance systems have
been shown to detect flu outbreaks earlier than is possible through
monitoring deaths from pneumonia or influenza. Increases in visits to
emergency departments by children for fever or respiratory problems
can provide an even earlier indicator. Researchers have not previously
examined in detail how fever and respiratory problems by age group
correlate with the predominant circulating respiratory viruses. Knowing
details like this would help public-health officials detect and respond to
influenza epidemics and pandemics. In this study, the researchers have
used data collected between 2001 and 2006 in New York City emergency
departments to investigate these aspects of syndromic surveillance for
influenza.
What Did the Researchers Do and Find? The researchers analyzed
emergency department visits categorized broadly into a fever and
respiratory syndrome (which provides an estimate of the total visits
attributable to influenza) or more narrowly into an influenza-like illness
syndrome (which specifically indicates fever with cough and/or sore
throat) with laboratory-confirmed influenza surveillance data. They found
that emergency department visits were highest during peak influenza
periods, and that the affect on different age groups varied depending on
the predominant circulating viruses. In early 2002, an epidemic
reemergence of B/Victoria-lineage influenza viruses caused increased
visits among school-aged children, while adult visits did not increase. By
contrast, during the 2003–2004 season, when the predominant virus was
an A/H3N2 Fujian-lineage influenza virus, excess visits occurred in all age
groups, though the relative increase was greatest and earliest among
school-aged children. During periods of documented respiratory
syncytial virus (RSV) circulation, increases in fever and respiratory
emergency department visits occurred in children under five years of
age regardless of influenza circulation. Finally, the researchers found that
excess visits to emergency departments for fever and respiratory
symptoms preceded deaths from pneumonia or influenza by about
two weeks.
What Do These Findings Mean? These findings indicate that excess
emergency department visits for fever and respiratory symptoms can
provide a reliable and timely surrogate measure of illness due to
influenza. They also provide new insights into how different influenza
viruses affect people of different ages and how the timing and
progression of each influenza season differs. These results, based on
data collected over only five years in one city, might not be generalizable
to other settings or years, warn the researchers. However, the present
results strongly suggest that the routine monitoring of influenza might
be improved by using electronic health-related data, such as emergency
department visit data, and by examining it specifically by age group.
Furthermore, by showing that school-aged children can be the first
people to be affected by seasonal influenza, these results highlight the
important role this age group plays in community-wide transmission of
influenza, an observation that could influence the implementation of
public-health strategies such as vaccination that aim to protect
communities during influenza epidemics and pandemics.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040247.
  US Centers for Disease Control and Prevention provides information
on influenza for patients and health professionals and on influenza
surveillance in the US (in English, Spanish, and several other
languages)
  World Health Organization has a fact sheet on influenza and on global
surveillance for influenza (in English, Spanish, French, Russian, Arabic,
and Chinese)
  The MedlinePlus encyclopedia contains a page on flu (in English and
Spanish)
  US National Institute of Allergy and Infectious Diseases has a feature
called ‘‘focus on flu’’
  A detailed report from the US Centers for Disease Control and
Prevention titled ‘‘Framework for Evaluating Public Health Surveillance
Systems for Early Detection of Outbreaks’’ includes a simple
description of syndromic surveillance
  The International Society for Disease Surveillance has a collaborative
syndromic surveillance public wiki
  The Anthropology of the Contemporary Research Collaboratory
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